GlassScriptPhysician profile
Leighton Kaonohi
NPI 1548518343
$506.20
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $368 · 2022: $24.39 · 2023: $101 · 2024: $13.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $113.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $380.92 | 2021-2023 | Aequalis Perform Reversed |
| Pacira Therapeutics, INC. | $29.95 | 2021 | |
| Heron Therapeutics, INC. | $24.39 | 2022 | |
| Avanos Medical | $22.18 | 2023 | On-Q* Pump and Accessories |
| Pacira Pharmaceuticals Incorporated | $21.22 | 2023 | Exparel, Zilretta, Iovera |
| Endo Pharmaceuticals INC. | $14.39 | 2023 | Xiaflex |
| Solventum Corporation | $13.15 | 2024 | Prevena, Prevena Restor Axioform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leighton Kaonohi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.